Consumer health, the business of selling health and wellness sustaining-brands in categories as diverse as pain relievers,brain-boosting yogurts.
Michael Winter
Consumer health, the business of selling health and wellness sustaining-brands in categories as diverse as pain relievers, brain-boosting yogurts, sports nutrition, baby food and bone supplement drinks, is poised to take off globally.
With consumers becoming ever more health-aware and knowledgeable, companies from both the pharma and consumer segments are competing hard to get a piece of the action.
Which players will successfully harness the segment’s potential? Whatever the outcome of the battle, talent will be a critical weapon, as interviews with C-suite executives from top food, personal care and OTC drug companies have recently shown.
The war for talent between pharma and consumer players looks set to be intense, with both sides keen - and ever more active - to lure away senior talent from their competitors to plug competence gaps and boost their own executive bench strength. This is easier said than done. Finding, attracting, convincing, and integrating this talent can be tough. It takes courage and vision for companies to move away from familiar territory and recruit a new breed of leader.
Top consumer health leaders tend to display four exceptional competency spikes.
Finding executives who meet these criteria is an issue facing consumer health businesses. In some cases they may need to take a lateral view of the talent pool, perhaps even looking to other sectors to find high-calibre leaders with the right profile.
Recruiting this kind of leadership talent, however, is merely the first step. Effective onboarding is absolutely essential. This involves companies making a serious commitment to integrating new talent. Only those companies that are truly committed to consumer health, have a clear vision and are ready to make a serious investment will attract outstanding talent that transcends the respective legacies of the pharma and consumer industries.
Michael Winter is a consultant with executive search and advisory firm Egon Zehnder.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
MDMA Therapy for Mental Health Conditions: Do the Benefits Outweigh the Risks?
October 25th 2024Despite a recent FDA Complete Response Letter issued to Lykos for midomafetamine capsules for the treatment of post-traumatic stress disorder, experts believe that the future is bright for psychedelic drugs that treat mental health conditions.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
The Impact of Artificial Intelligence on the Creation of Medicines
October 24th 2024Najat Khan, chief R&D officer, chief commercial officer, Recursion, and Fred Hassan, director, Warburg Pincus, discuss how artificial intelligence can help reduce healthcare costs at the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.